Specifically, both copies of the gene encoding ICP34.5 have been deleted, which is expected to reduce pathogenicity and provide tumor selective replication due to the oncogenic disruption of the protein kinase R (PKR) pathway [8]. This evidence concerns the gene EIF2AK2 and neoplasm.